Dana Dlouhá - Concepedia

Author

Dana Dlouhá

Institute of Clinical and Experimental Medicine ORCID

Also Known As

D DLOUHA, D Dlouha, D Dlouhá, D. DLOUHA, D. DLOUHÁ, D. Dlouha, D. Dlouhá, DANA DLOUHA, Dana DLOUHA, Dana Dlouha

Publications

895

Citations

H-Index

Concepts

All Affiliations

Institute of Clinical and Experimental Medicine Charles University General University Hospital in Prague Masaryk University Czech Technical University in Prague

About

Dana Dlouhá is an author at Institute of Clinical and Experimental Medicine specializing in medicine, genetic epidemiology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	333
2	Public Health	7	7	159
3	Epidemiology	7	7	159
4	Diabetes	3	3	54
5	Biostatistics	1	1	11

Dana Dlouhá

Publications

680

Citations

H-Index

Page 1

	Year	Citations
Comparison of the Relative Telomere Length Measured in Leukocytes and Eleven Different Human Tissues Dana Dlouhá, J. MALUSKOVA, Ivana Králová Lesná, Physiological Research	2014	125
A FTO variant and risk of acute coronary syndrome Jaroslav A. Hubáček, Vladimír Staněk, M Gebauerová, Clinica Chimica Acta ThrombosisCardiovascular DiseaseFto VariantCardiologyMedicine	2010	65
The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population Jaroslav A. Hubáček, Ondřej Viklický, Dana Dlouhá, Nephrology Dialysis Transplantation	2011	53
FTO and MC4R gene variants determine BMI changes in children after intensive lifestyle intervention Lukáš Zlatohlávek, Michal Vráblík, Eva Motyková, Clinical Biochemistry ObesityMetabolic SyndromeChildhood ObesityGeneticsGenetic Epidemiology	2012	51
CCR5Δ32 Deletion as a Protective Factor in Czech First-Wave COVID-19 Subjects Jaroslav A. Hubáček, Ladislav Dušek, Ondřej Májek, Physiological Research Truncated ProteinCcr5delta32 CarriersImmunologyViral PathogenesisCovid-19 Epidemiology	2021	44
ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors Jaroslav A. Hubáček, Ladislav Dušek, Ondřej Májek, Clinica Chimica Acta Viral EvolutionMedicineImmunologyHuman PolymorphismViral Structural Protein	2021	43
Body Mass Index Change in Females After Short-Time Life Style Intervention Is Not Dependent on the FTO Polymorphisms Dana Dlouhá, Pavel Suchánek, Věra Lánská, Physiological Research	2011	34
Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study Pavel Trunečka, Irena Míková, Dana Dlouhá, Digestive and Liver Disease TransplantationSolid Organ TransplantationGenetic EpidemiologyPathologyGraft Steatosis	2018	31
The FTO variant is associated with chronic complications of diabetes mellitus in Czech population Jaroslav A. Hubáček, Dana Dlouhá, Marta Klementová, Gene ObesityMetabolic SyndromeDiabetes ManagementCardiovascular DiseaseFto Variant	2017	28
Association between FTO 1st intron tagging variant and telomere length in middle aged females. 3PMFs study Dana Dlouhá, Jan Piťha, Věra Lánská, Clinica Chimica Acta GeneticsGenetic EpidemiologyTelomere LengthFto 1StMiddle Aged Females	2012	27

Page 1